Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases

Details for Australian Patent Application No. 2006329042 (hide)

Owner MEDA Pharma GmbH & Co KG

Inventors Kastrup, Horst; Szelenyi, Istvan; Maus, Joachim; Cnota, Peter; Bauhofer, Artur

Agent Spruson & Ferguson

Pub. Number AU-B-2006329042

PCT Pub. Number WO2007/071313

Priority 60/752,058 21.12.05 US

Filing date 1 December 2006

Wipo publication date 28 June 2007

Acceptance publication date 2 February 2012

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/071313 Priority application(s): WO2007/071313

5 June 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases

2 February 2012 Application Accepted

  Published as AU-B-2006329042

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006329052-Curable fluorinated copolymers and coatings and processes thereof

2006329040-2 -Phenylethylamino derivatives as calcium and/or sodium channel modulators